Skip to main content
. 2015 Apr 6;290(23):14441–14453. doi: 10.1074/jbc.M114.628826

TABLE 2.

IC50 evaluation of structural derivatives of Compounds 3 and 17 with 72 h of treatment in the KMS11 cell line

Compound ID IC50 (for growth inhibition)
μm
19 20.48
21 13.16
23 20.58
24 8.82
25 35.31
26 6.67
27 9.7
29 13.98
31 21.19
33 15.44
35 7.11
36 17.00
38 9145
39 3.31
40 30.97
41 8.68